SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing a significant surge in momentum as investors anticipate a potential short squeeze ahead of upcoming earnings, fueled by elevated short interest and heavy trading volume. The community is actively tracking institutional participation and debating whether the stock's recent volatility signals a broader breakout in the voice AI sector.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is trending as the community highlights its recent recognition in a major quantum computing paper, which analysts believe validates its post-quantum security credentials. Enthusiasts are actively debating the long-term potential of the chain's institutional developments while some remain skeptical about its price performance compared to historical highs.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing renewed community activity, with long-term holders debating the project's potential for future growth while some participants express frustration over price stagnation. Sentiment remains highly polarized, oscillating between optimistic calls for a market breakout and ongoing skepticism regarding the token's long-term utility.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA is seeing a massive surge in volume and retail interest driven by high-profile endorsements from investors like Bill Ackman and Michael Burry, who are highlighting the stock as significantly undervalued. The community is actively debating the likelihood of a near-term IPO, potential conservatorship exit, and the influence of political rhetoric on the stock's future.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending as the community reacts to the company's announcement of an end-of-Phase 2 meeting with the FDA and the established registration path for its lead program, CAD-1005. While some investors are optimistic about the upcoming Phase 3 trial for heparin-induced thrombocytopenia, others remain skeptical due to persistent concerns regarding dilution and the frequent use of bot-driven spam to artificially drive social sentiment.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

Community sentiment regarding the MELANIA token remains overwhelmingly negative, with users characterizing the asset as a pump-and-dump scheme associated with the Trump family. Investors frequently highlight significant losses and criticize the lack of utility, while discussions continue to draw parallels to broader concerns regarding political influence and transparency.

StealthGas, Inc. engages in the provision of international energy seaborne transportation services to liquefied petroleum gas sectors. It owns fleet of vessels that carry petroleum and petrochemical gas products in liquefied form such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer. The company was founded in December 22, 2004 and is headquartered in Athens, Greece.

StealthGas Inc

StealthGas Inc. is trending as investors highlight its debt-free balance sheet, strong cash position, and solid earnings performance in a cyclical LPG shipping market. Community discussions center on the company's attractive valuation relative to its assets, with some market participants monitoring its potential to capitalize on rising charter rates driven by global energy demand.

ProShares Trust II - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver (AGQ) is seeing intense volatility as market participants debate whether current geopolitical tensions, industrial demand, and low physical inventories will fuel a sustained short squeeze. Community sentiment is deeply divided, with many traders closely monitoring the relationship between spot silver prices, the U.S. dollar, and potential intervention from global markets like Shanghai.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is trending as investors weigh its aggressive pivot toward AI and high-performance computing infrastructure against concerns regarding capital expenditures, share dilution, and the absence of a long-awaited strategic AI partnership. While some community members remain bullish on the company's efficient mining operations and energy-linked assets, others are actively debating high short interest and management's capital allocation strategy ahead of upcoming earnings.

ETF Opportunities Trust - T-Rex 2X Inverse MSTR Daily Target ETF

T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ is trending as investors actively debate the sustainability of MicroStrategy's rally, with a vocal community of traders utilizing the 2X inverse ETF to bet against MSTR's valuation. While some participants are aggressively scaling into short positions to hedge against potential Bitcoin volatility, others are debating whether current price action represents a temporary correction or a deeper structural decline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Supernus Pharmaceuticals, Inc. $SUPN Shares Sold by Pictet Asset Management Holding SA

Pictet Asset Management Holding SA cut its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 5.0% during the fourth quarter, according to the company in its most recent Form...

Bausch Health (BHC) Lags Q1 Earnings Estimates

Bausch (BHC) delivered earnings and revenue surprises of -3.11% and +4.72%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Biogen Beats Q1 Earnings Estimates but Cuts 2026 EPS View on M&A Costs

Biogen beats Q1 earnings and revenue estimates, fueled by new drug growth, but cuts 2026 EPS outlook to reflect M&A costs.

Supernus Pharmaceuticals (NASDAQ:SUPN) Rating Increased to Hold at Zacks Research

Zacks Research upgraded Supernus Pharmaceuticals from a "strong sell" rating to a "hold" rating in a report on Monday...

Supernus Pharmaceuticals (SUPN) to Release Quarterly Earnings on Tuesday

Supernus Pharmaceuticals (NASDAQ:SUPN) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-supernus-pharmaceuticals-inc-stock...

Biogen Q1 Earnings: Can New Launches Offset Declining MS Franchise?

Biogen heads into Q1 earnings with new drugs like Skyclarys and Zurzuvae driving growth as legacy MS products face rising competitive pressure.

Ruffer LLP Sells 21,058 Shares of Supernus Pharmaceuticals, Inc. $SUPN

Ruffer LLP lessened its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 38.0% during the fourth quarter, according to its most recent filing with the Securities...

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Receives Consensus Rating of "Hold" from Analysts

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Get Free Report) has been given an average recommendation of "Hold" by the seven analysts that are presently covering the firm, Marketbeat Ratings...

Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig

Alpha Cognition Inc. (Nasdaq: ACOG) (Alpha Cognition, or the Company), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced the appointment of Bethany Sensenig to its Board of Directors, effective April 15, 2026. Ms...

Phocas Financial Corp. Acquires Shares of 81,320 Supernus Pharmaceuticals, Inc. $SUPN

Phocas Financial Corp. acquired a new stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 81,320 shares of the specialty pharmaceu...

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.

SUPN
Supernus Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SUPN News

SUPNSupernus Pharmaceuticals Inc